Frontispiece: Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: Systematic review, improvements and future challenges (EXP2 1/2024)
{"title":"Frontispiece: Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: Systematic review, improvements and future challenges (EXP2 1/2024)","authors":"Hongyu Liu, Yunjian Yu, Alideertu Dong, Mahmoud Elsabahy, Ying-Wei Yang, Hui Gao","doi":"10.1002/EXP.20240106","DOIUrl":null,"url":null,"abstract":"<p>In review number 20230092, Hui Gao and co-workers summarized strategies to combat <i>F. nucleatum</i> and <i>F. nucleatum</i> biofilms for improving CRC treatment, including natural extracts, inorganic chemicals, organic chemicals, polymers, inorganic organic hybrid materials, bacteriophages, probiotics, and vaccines. The review provides an outlook on the antimicrobial specificity, potential clinical implications, challenges, and future improvements of these antimicrobial approaches in CRC management.\n\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":72997,"journal":{"name":"Exploration (Beijing, China)","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/EXP.20240106","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration (Beijing, China)","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/EXP.20240106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In review number 20230092, Hui Gao and co-workers summarized strategies to combat F. nucleatum and F. nucleatum biofilms for improving CRC treatment, including natural extracts, inorganic chemicals, organic chemicals, polymers, inorganic organic hybrid materials, bacteriophages, probiotics, and vaccines. The review provides an outlook on the antimicrobial specificity, potential clinical implications, challenges, and future improvements of these antimicrobial approaches in CRC management.